Back to Walleye Capital LLC Walleye Capital LLC

VKTXVKTX

Showing 8 of 21 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in VIKING THERAPEUTICS INC

Yes. Walleye Capital holds 11,302 shares of VKTX (Viking Therapeutics), worth $440,891, as of its Q2 2026 13F filing. It increased the position by 6,729 shares (+147.2%) from Q1 2026. Walleye Capital has held VKTX since Q1 2024, across 10 quarterly 13F filings.

Current Value

$440,891

Current Shares

11,302

Total Value Change

-$55,396

Total Shares Change

+3,463

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11,302
+147.2%
$440,8910.0%$39.01
39
2026-Q1
Decreased
4,573
-94.7%
$148,8050.0%$32.54
0
2025-Q4
Increased
86,371
+53.5%
$3M0.0%$35.18
37
2025-Q3
Increased
56,258
+3345.1%
$1.5M0.0%$26.28
41
2025-Q2
Decreased
1,633
-95.4%
$43,2750.0%$26.50
0
2025-Q1
Increased
35,499
+4971.3%
$857,3010.0%$24.15
40
2024-Q4
Decreased
700
-91.1%
$28,1680.0%$40.24
0
2024-Q3
Increased
7,839
+26.8%
$496,2870.0%$63.31
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used